Switch theme
Sign up to access all valuation multiples
Eden Research PLC is a UK-based company that develops and supplies biopesticide products and natural microencapsulation technologies to the crop protection, animal health, and consumer products industries. It operates through Agrochemical, Consumer products, and Animal health segments. It offers a range of product categories under Foliar Diseases Control, Soil Pest, Protected Glass House Crops, Vascular Diseases Control, and Post-Harvest Applications.
1995
19
LTM Revenue $6.2M
LTM EBITDA -$1.9M
$22.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Eden Research has a last 12-month revenue (LTM) of $6.2M and a last 12-month EBITDA of -$1.9M.
In the most recent fiscal year, Eden Research achieved revenue of $4.3M and an EBITDA of -$8.4M.
Eden Research expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Eden Research valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.2M | XXX | $4.3M | XXX | XXX | XXX |
| Gross Profit | $6.2M | XXX | $2.4M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | -$1.9M | XXX | -$8.4M | XXX | XXX | XXX |
| EBITDA Margin | -31% | XXX | -197% | XXX | XXX | XXX |
| EBIT | -$2.7M | XXX | -$2.5M | XXX | XXX | XXX |
| EBIT Margin | -44% | XXX | -58% | XXX | XXX | XXX |
| Net Profit | -$2.3M | XXX | -$8.7M | XXX | XXX | XXX |
| Net Margin | -38% | XXX | -203% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Eden Research's stock price is GBP 0 (or $0).
Eden Research has current market cap of GBP 20.5M (or $27.6M), and EV of GBP 17.0M (or $22.9M).
See Eden Research trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22.9M | $27.6M | XXX | XXX | XXX | XXX | $-0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Eden Research has market cap of $27.6M and EV of $22.9M.
Eden Research's trades at 5.3x EV/Revenue multiple, and -2.7x EV/EBITDA.
Equity research analysts estimate Eden Research's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eden Research has a P/E ratio of -11.8x.
See valuation multiples for Eden Research and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $27.6M | XXX | $27.6M | XXX | XXX | XXX |
| EV (current) | $22.9M | XXX | $22.9M | XXX | XXX | XXX |
| EV/Revenue | 3.7x | XXX | 5.3x | XXX | XXX | XXX |
| EV/EBITDA | -11.9x | XXX | -2.7x | XXX | XXX | XXX |
| EV/EBIT | -8.4x | XXX | -9.1x | XXX | XXX | XXX |
| EV/Gross Profit | 3.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -11.8x | XXX | -3.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -4.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialEden Research's last 12 month revenue growth is 9%
Eden Research's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Eden Research's rule of 40 is -93% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eden Research's rule of X is -9% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Eden Research and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | -31% | XXX | -197% | XXX | XXX | XXX |
| EBITDA Growth | -16% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -93% | XXX | -188% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -9% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 114% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Hydratec Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Brazil Potash | XXX | XXX | XXX | XXX | XXX | XXX |
| House of Agriculture | XXX | XXX | XXX | XXX | XXX | XXX |
| Gujarat State Fertilizers & Chemicals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eden Research acquired XXX companies to date.
Last acquisition by Eden Research was XXXXXXXX, XXXXX XXXXX XXXXXX . Eden Research acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Eden Research founded? | Eden Research was founded in 1995. |
| Where is Eden Research headquartered? | Eden Research is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Eden Research have? | As of today, Eden Research has 19 employees. |
| Who is the CEO of Eden Research? | Eden Research's CEO is Mr. Sean Michael Smith. |
| Is Eden Research publicy listed? | Yes, Eden Research is a public company listed on LON. |
| What is the stock symbol of Eden Research? | Eden Research trades under EDEN ticker. |
| When did Eden Research go public? | Eden Research went public in 2012. |
| Who are competitors of Eden Research? | Similar companies to Eden Research include e.g. Fertiglobe, Hydratec Industries, Brazil Potash, House of Agriculture. |
| What is the current market cap of Eden Research? | Eden Research's current market cap is $27.6M |
| What is the current revenue of Eden Research? | Eden Research's last 12 months revenue is $6.2M. |
| What is the current revenue growth of Eden Research? | Eden Research revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Eden Research? | Current revenue multiple of Eden Research is 3.7x. |
| Is Eden Research profitable? | Yes, Eden Research is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eden Research? | Eden Research's last 12 months EBITDA is -$1.9M. |
| What is Eden Research's EBITDA margin? | Eden Research's last 12 months EBITDA margin is -31%. |
| What is the current EV/EBITDA multiple of Eden Research? | Current EBITDA multiple of Eden Research is -11.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
